Overview
Margareth Dalcolmo is a pulmonology specialist with an H-index of 34 at Fiocruz (Member). Has been published in The Lancet, New England Journal of Medicine, The New England journal of medicine. Based in Unknown, Unknown, Global.
Biography
The COVID-19 vaccination campaign in Brazil is an ongoing mass immunization campaign for the COVID-19 pandemic in Brazil. It started on 17 January 2021, when the country had 210 thousand deaths.
Affiliations & Institutions
Research Impact
5 Publications
0 Total Citations
Publication Timeline
Published In
J Bras PneumolLancet Infect DisPulm Med
Key Publications
Tuberculosis series.
Tuberculosis: where are we?
Bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) for multidrug- or rifampin-resistant tuberculosis: a systematic review.
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial.
Pulmonary tuberculosis.
Areas of Expertise
Medical Specialties
Clinical Knowledge & Procedures
Media Archive
Related Specialists
View AllAre you Margareth Dalcolmo?
Claim your MDRPedia profile to unlock analytics, manage your digital legacy, and receive your verified badge.